ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 278

Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting

Jun Chu1, Elaine Poncio 2, Yenealem Temesgen-Oyelakin 2, Michael Davis 3, Isabel Ochoa-Navas 2, Sarthak Gupta 4, Zerai Manna 2, Marquis Chapman 1, Eileen Chu 5, Aidan Donnellan 6 and Sarfaraz Hasni 7, 1National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, 2NIAMS/NIH, Bethesda, 3NIAMS/NIH, Bethesda, MD, 4Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, 5National Institutes of Health, Derwood, MD, 6National Institutes of Health, Bethesda, 7NIAMS, National Institutes of Health, Bethesda, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Quality Indicators, SLE and tertiary

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The care for patients with lupus is complex as they may exhibit multiple concomitant medical and socioeconomic issues. To address all their needs according to the current guidelines is a daunting task in busy outpatient practices. However, incorporating quality indicators in patient care has been found to decrease mortality and morbidity, improve patient satisfaction, and reduce costs. To improve the quality of care following recommendations from published guidelines, ACR, and EULAR, we embarked on a comprehensive quality improvement project by developing a checklist tool that incorporates the major SLE-Quality indicators (SLE-QI).

Methods: The project was launched in October 2017. A SLE-QI checklist detailing quality indicators was created based on published recommendations for standard of care. The checklist included a set of 20 SLE-QIs that address several important aspects of SLE care including diagnosis and disease monitoring, general prevention strategies, screening for comorbidities, drug toxicity monitoring, assessment of renal disease, reproductive health, and quality of life in daily practice. A standardized document template for clinic visits was developed that incorporated these quality indicators. Clinic progress notes were reviewed weekly to determine if these indicators were used and addressed. If SLE-QIs were missing, efforts were made to reach out to providers to address the missing QIs.

Results: At the beginning of the assessment, documentation of SLE-QIs was generally poor and inconsistent. For example, vaccinations was only at 60% compliance while screening for cardiovascular risk was only at 3% compliance. Since documentation was not standardized, it was difficult to assess if SLE-QIs were being done. Implementing SLE-QI in standardized notes resolved these concerns, bringing compliance close to 100% compliance for the 20 identified SLE quality indicators.

Conclusion: Standardized progress notes incorporating QI indicators is a feasible strategy that helps streamline data extraction for future clinical research. Additionally, incorporating patient outcome tools improves the ability to perform treat-to-target strategies for SLE.  This ongoing QI project may potentially improve overall patient outcomes and lead to reduce health care costs.


Disclosure: J. Chu, None; E. Poncio, None; Y. Temesgen-Oyelakin, None; M. Davis, None; I. Ochoa-Navas, None; S. Gupta, None; Z. Manna, None; M. Chapman, None; E. Chu, None; A. Donnellan, None; S. Hasni, None.

To cite this abstract in AMA style:

Chu J, Poncio E, Temesgen-Oyelakin Y, Davis M, Ochoa-Navas I, Gupta S, Manna Z, Chapman M, Chu E, Donnellan A, Hasni S. Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/improving-a-sle-quality-indicator-tool-in-an-outpatient-tertiary-care-setting/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-a-sle-quality-indicator-tool-in-an-outpatient-tertiary-care-setting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology